Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002)

Reducing radiation treatment dose could improve the quality of life (QOL) of patients with good-risk human papillomavirus–associated oropharyngeal squamous cell carcinoma (OPSCC). Whether reduced-dose radiation produces disease control and QOL equivalent to standard chemoradiation is not proven. PAT...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Yom, Sue S., Torres-Saavedra, Pedro, Caudell, Jimmy J., Waldron, John N., Gillison, Maura L., Xia, Ping, Truong, Minh T., Kong, Christina, Jordan, Richard, Subramaniam, Rathan M., Yao, Min, Chung, Christine H., Geiger, Jessica L., Chan, Jason W., O'Sullivan, Brian, Blakaj, Dukagjin M., Mell, Loren K., Thorstad, Wade L., Jones, Christopher U., Banerjee, Robyn N., Lominska, Christopher, Le, Quynh-Thu
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2021
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8078254/
https://ncbi.nlm.nih.gov/pubmed/33507809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.20.03128
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados